Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir DF Monotherapy vs Combination in Lamivudine-Resistant HBV
NCT00737568Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by Gilead Sciences. Started Sep 2008; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00737568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737568.